Year: 2021

DEERFIELD, Ill., Dec. 20, 2021 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate in the 2022 H.C. Wainwright Virtual BioConnect Conference taking place January 10-13, 2022. A recording of the Company’s presentation will be available Monday, January 10, 2022 at 7am ET. To access please visit the investor relations page of the Company’s website at surgalign.com/investors/. Replays of the webcasts will be archived on the website for approximately 90 days. About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital surgery and is building out its digital surgery platform to drive...

TYLER, Texas, Dec. 20, 2021 (GLOBE NEWSWIRE) — Southside Bancshares, Inc. (the “Company”) (NASDAQ:SBSI), the holding company of Southside Bank (the “Bank”), announced the appointment of Alton L. Frailey to the Company’s board of directors on November 24, 2021, effective January 1, 2022, increasing the size of the Company’s board to 17 members. Mr. Frailey was also appointed to the Bank’s board of directors, effective January 1, 2022, increasing the size of the Bank board to 18 members. Residing in the greater Houston area, Mr. Frailey is President of Alton L. Frailey & Associates, LLC, specializing in leadership development, community engagement, school board team building and executive coaching. Mr. Frailey has been involved in education for 35 years, serving most recently as the past superintendent for Katy Independent School...

RALEIGH, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that the U.S. District Court of Delaware has issued an opinion in favor of BDSI in the company’s patent litigation against Alvogen Group, Inc. and its affiliates, who filed an Abbreviated New Drug Application (ANDA) for BDSI’s BELBUCA® product on May 23, 2018. The opinion by the trial judge upholds the validity of claims in BDSI’s patents 8,147,866 (the ‘866 patent), which expires in 2027, and 9,901,539 (the ‘539 patent), which expires in 2032. Alvogen conceded infringement of these claims. Accordingly, BDSI expects market exclusivity of BELBUCA against Alvogen until 2032. “We are pleased with...

LOS ANGELES, CA, Dec. 20, 2021 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the “Company”), a biopharmaceutical company pioneering Tissue Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, today announced the closing of its initial public offering of 4,200,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $21,000,000, before deducting underwriting discounts, commissions and offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 630,000 shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments. The shares began trading on the Nasdaq Capital Market on December 16, 2021 under the ticker symbol “IMMX.” ThinkEquity...

Irvine, California, Dec. 20, 2021 (GLOBE NEWSWIRE) — McLaren Technology Acquisition Corp. (the “Company”) announced today that, commencing December 23, 2021, holders of the 20,125,000 units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A common stock and warrants included in the units. Class A common stock and warrants that are separated will trade on the Nasdaq Stock Market LLC under the symbols “MLAI” and “MLAIW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on the Nasdaq Stock Market LLC under the symbol “MLAIU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to...